SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001600132-20-000062
Filing Date
2020-06-09
Accepted
2020-06-09 16:01:52
Documents
1
Period of Report
2020-06-05

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_159173289350800.html 4  
1 FORM 4 wf-form4_159173289350800.xml 4 4423
  Complete submission text file 0001600132-20-000062.txt   5928
Mailing Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059
Business Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059 908-574-4770
Bellerophon Therapeutics, Inc. (Issuer) CIK: 0001600132 (see all company filings)

IRS No.: 473116175 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O PUISSANCE CAPITAL MANAGEMENT LP 950 THIRD AVENUE, 25TH FLOOR NEW YORK NY 10022
Business Address
Wang Theodore T (Reporting) CIK: 0001694061 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36845 | Film No.: 20951808